Editas Medicine
Benjamin Diner, Ph.D., is a highly experienced scientist specializing in advanced technologies and drug discovery. Currently serving as Senior Scientist II at Editas Medicine since September 2016, Benjamin Diner has held various positions within the organization, including Senior Scientist I and Scientist roles. Prior to this, Benjamin Diner worked as a Staff Research Scientist in the Department of Molecular Biology at Princeton University from June 2016 to September 2016. Educationally, Benjamin Diner earned a Ph.D. in Cell/Cellular and Molecular Biology from Princeton University in May 2016, following a Master of Arts in Biochemistry, Cell and Molecular Biology from the same institution. Benjamin Diner completed a Bachelor of Arts in Biochemistry and Molecular Biology at Cornell University in May 2010.
This person is not in any teams
Editas Medicine
5 followers
Editas Medicine is a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Their goal is to discover, develop, manufacture, and commercialize transformative medicines for a range of serious diseases, including eye diseases, blood diseases, and cancer.